Clinical and economic data from real patient care occupy an increasingly important area in the evaluation of therapies, since, unlike clinical studies, no patient selection takes place here and broad insights into therapies and the resulting costs can be gained.
The analysis and presentation of clinical parameters, clinical processes and detailed treatment behaviour in individual therapy sequences are becoming increasingly important – both in large and, above all, in smaller tumour indications.
The basic data project, which has been running since 2012, offers a consistent and longitudinally updated recording of more than 20,000 patient histories under drug-based tumour therapy and an existing database through which various offers for data analyses with relevant case numbers can be implemented, or whose data can be expanded by targeted supplementary projects to answer specific questions.
The analysis and presentation of medical and technical performance data enable calculations of direct cost structures of individual therapy sections or entire patient histories. Among other things, all patients undergoing drug tumour therapy are documented anonymously in the centres of the participating oncologists. Due to this consistent data collection, we can implement various offers for data analysis with relevant case figures for you, such as, among others: